Calydon Capital Trims Position in Cigna Group $CI

Calydon Capital decreased its holdings in shares of Cigna Group (NYSE:CI) by 67.9% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,052 shares of the health services provider’s stock after selling 2,224 shares during the quarter. Calydon Capital’s holdings in Cigna Group were worth $303,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Harbor Capital Advisors Inc. lifted its position in Cigna Group by 119.5% during the third quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock worth $26,000 after buying an additional 49 shares during the period. Collier Financial purchased a new position in shares of Cigna Group during the 3rd quarter worth about $34,000. Traub Capital Management LLC acquired a new position in shares of Cigna Group in the 2nd quarter valued at $48,000. Founders Capital Management boosted its holdings in Cigna Group by 53.0% in the third quarter. Founders Capital Management now owns 153 shares of the health services provider’s stock valued at $44,000 after acquiring an additional 53 shares during the last quarter. Finally, Twin Peaks Wealth Advisors LLC purchased a new stake in Cigna Group during the second quarter valued at about $52,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Insider Buying and Selling

In other Cigna Group news, insider Everett Neville sold 1,719 shares of the stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $496,636.29. Following the transaction, the insider directly owned 5,670 shares in the company, valued at $1,638,119.70. This represents a 23.26% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Nicole S. Jones sold 2,307 shares of the business’s stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $666,515.37. Following the completion of the sale, the insider directly owned 32,647 shares of the company’s stock, valued at $9,432,044.77. The trade was a 6.60% decrease in their position. The SEC filing for this sale provides additional information. Corporate insiders own 0.70% of the company’s stock.

Cigna Group Price Performance

CI opened at $267.15 on Monday. Cigna Group has a twelve month low of $239.51 and a twelve month high of $350.00. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.74. The firm has a market cap of $70.40 billion, a price-to-earnings ratio of 12.04, a PEG ratio of 0.93 and a beta of 0.27. The company has a fifty day simple moving average of $279.60 and a 200 day simple moving average of $282.70.

Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, beating analysts’ consensus estimates of $7.88 by $0.20. The company had revenue of $72.50 billion during the quarter, compared to analysts’ expectations of $69.53 billion. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The firm’s revenue for the quarter was up 10.4% on a year-over-year basis. During the same period in the prior year, the company posted $6.64 EPS. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Equities research analysts expect that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, March 19th. Shareholders of record on Thursday, March 5th will be issued a dividend of $1.56 per share. The ex-dividend date is Thursday, March 5th. This represents a $6.24 annualized dividend and a yield of 2.3%. This is a boost from Cigna Group’s previous quarterly dividend of $1.51. Cigna Group’s dividend payout ratio (DPR) is presently 28.13%.

Wall Street Analyst Weigh In

CI has been the topic of several research analyst reports. Leerink Partners lifted their price objective on Cigna Group from $270.00 to $297.00 and gave the company a “market perform” rating in a research note on Friday, February 6th. Deutsche Bank Aktiengesellschaft raised their price target on shares of Cigna Group from $301.00 to $304.00 and gave the company a “buy” rating in a report on Tuesday, February 10th. Robert W. Baird reduced their price target on shares of Cigna Group from $372.00 to $315.00 and set an “outperform” rating on the stock in a research report on Thursday, December 11th. Barclays dropped their price objective on shares of Cigna Group from $305.00 to $303.00 and set an “overweight” rating for the company in a research report on Friday, February 6th. Finally, Royal Bank Of Canada reduced their target price on shares of Cigna Group from $344.00 to $333.00 and set an “outperform” rating on the stock in a report on Friday, February 6th. One research analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $333.11.

Cigna Group News Summary

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Sanford C. Bernstein upgraded Cigna to “outperform” and raised its price target to $358, citing PBM reform as a clearing event and improved outlook for Evernorth — a catalyst for multiple analysts to raise estimates. Bernstein upgrades CVS and Cigna, citing PBM reform as key clearing event
• Positive Sentiment: Zacks notes CI trades below the industry P/E and highlights Evernorth growth, steady earnings beats and buybacks as supports for the investment case — a valuation/earnings combo that helps explain buying interest. Cigna Stock Trades Below Industry P/E: Is It Worth Holding Now?
• Neutral Sentiment: A valuation review highlights recent share-price weakness versus the specialty-pharmacy growth narrative — useful context for investors weighing whether current discounts already reflect execution risks. Evaluating Cigna Group (CI) Valuation After Recent Share Price Weakness And Specialty Pharmacy Growth Narrative
• Neutral Sentiment: A head-to-head comparison with CVS frames Cigna as the play for stronger earnings quality and capital discipline, while reminding long-term investors to consider income, stability and valuation differences when choosing exposure. CVS vs Cigna: Which Healthcare Giant Belongs in Your Retirement Portfolio?
• Neutral Sentiment: Zacks’ broader industry outlook continues to single out major HMOs (including Cigna) as key players in a sector balancing tech-enabled growth and policy/operational headwinds. Zacks Industry Outlook Highlights UnitedHealth, The Cigna, Humana and Centene
• Negative Sentiment: Barclays and commentators warn that the timing of a CEO change could surprise investors and introduce strategic/operational uncertainty during a critical execution window. Management transition risk may weigh on sentiment until plans are clearer. The Cigna Group (CI) CEO Change Timing May Come As Surprise to Some Investors, According to Barclays
• Negative Sentiment: Industry pieces flag escalating medical costs, nursing shortages and margin pressure as sector-wide risks that could blunt near-term earnings leverage for HMOs, including Cigna. 4 HMO Stocks to Watch Despite Escalating Costs, Nursing Shortage

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.